Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05687149 · ClinicalTrials.gov registry record
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
A clinical trial of Fanconi Anemia and Inherited Bone Marrow Failure Syndrome, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT05687149: Recruiting study of Fanconi Anemia and Inherited Bone Marrow Failure Syndrome, sponsored by National Cancer Institute (NCI).
NCT05687149 is a study of Fanconi Anemia and Inherited Bone Marrow Failure Syndrome that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 200 participants, below the 323-participant average among 15 other Fanconi Anemia trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05687149, a study of Fanconi Anemia and Inherited Bone Marrow Failure Syndrome, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Fanconi anemia (FA) is an inherited disorder. People with FA are more likely to get certain cancers, especially squamous cell carcinoma (SCC). These cancers usually appear first in the mouth, esophagus, and genital and anal areas. Early detection of SCCs may help improve survival rates for people with FA. Objective: This natural history study will regularly screen people with FA for SCC. Eligibility: People aged 12 years and older with FA or a prior cancer diagnosis. Children aged 8 to 11 years with FA may also be eligible. Design: Participants will receive a comprehensive screening for cancer or early signs of cancer. Participants will have a physical exam. They will provide blood and saliva samples. Cells will be collected by rubbing a swab on the inside of the cheeks. A skin sample may be removed from the back, buttocks, or inside of the upper arm. Participants will have pictures taken of their mouth. Any mouth sores will be mapped. Cells will be collected from the sores with a small brush. Specialists will examine the participant s ears, nose, throat, teeth, and skin. Adult participants may have a gastrointestinal exam or pelvic exam. Participants may have an endoscopy. A long tube with a camera and a light will be inserted through the mouth and down into the stomach. Participants may have a liver ultrasound. A wand will be pressed against their belly to get pictures of the organs inside the body. Participants will have screenings every year for up to 10 years. Each visit will last up to 3 days. They will have remote follow-up visits every 6 - 8 months....
Primary Outcome
Prospectively screen individuals with FA for early indicators for the development of esophageal and anogenital SCC.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-03-23 |
| Est. Completion | 2035-12-31 |
What NCT05687149 shows while recruiting
NCT05687149 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 323-participant average among 15 other Fanconi Anemia trials with a reported enrollment target (38% lower).
The record links to 2 conditions, with Fanconi Anemia appearing as the primary indexed condition, and to 0 interventions.
NCT05687149 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT05687149 about?
NCT05687149 is a clinical study titled "Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia". Background: Fanconi anemia (FA) is an inherited disorder. People with FA are more likely to get certain cancers, especially squamous cell carcinoma (SCC). These cancers usually appear first in the mouth, esophagus, and genital and anal areas. Early detection of SCCs may help improve survival rates ...
What is the current status of trial NCT05687149?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-03-23. Estimated completion is 2035-12-31.
What conditions does trial NCT05687149 study?
This clinical trial studies the following conditions: Fanconi Anemia, Inherited Bone Marrow Failure Syndrome.
Who is sponsoring clinical trial NCT05687149?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05687149 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fanconi Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05687149's enrollment target sits among peer trials
200 3rd of 15 higher than 13 of 15 other Fanconi Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fanconi Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After Being Conditioned With a Regimen Containing Briquilimab
RECRUITING · Phase 1
-
Role of Acetaldehyde in the Development of Oral Cancer
RECRUITING · NA
-
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
RECRUITING · Phase 2
-
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
RECRUITING · Phase 2
-
Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
RECRUITING
-
Cancer in Inherited Bone Marrow Failure Syndromes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI